Plain-English translation of NCT07657650 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether new imaging scans—specifically PET and SPECT scans—can better predict which patients with ischemic heart failure (severe heart failure caused by clogged arteries) will improve after receiving revascularization surgery or angioplasty. Currently, doctors use older imaging methods to decide who should have these procedures, but those methods don't always accurately predict who will benefit. This study hopes to develop better tools to identify the right patients for surgery.
Not all patients with severe heart failure improve after revascularization surgery, and the surgery carries real risks. Doctors need better ways to identify beforehand which patients are most likely to benefit, rather than relying on older imaging methods that have proven unreliable in major international studies.
You likely qualify if…
You likely don't qualify if…
You will have three special imaging scans—PET and SPECT scans—to look at how your heart muscle is working and what kind of damage it has. These scans happen before your scheduled heart surgery or angioplasty. After your surgery, you will return for a follow-up visit at 12 months so doctors can see how well your heart recovered and check for any complications. The study team will also review your blood work and medical records.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
China